Rabies Diagnostics Market - Forecast(2024 - 2030)

Report Code: HCR 83871 Report Format: PDF + Excel

Rabies Diagnostics Market Overview

Rabies Diagnostics Market size is estimated to reach $2,030 million by 2026, growing at a CAGR of 4.1% over 2021-2026. Rabies is associated with the nervous system that are caused owing to rhabdovirus and are transmitted by an animal bite. Rabies is a viral infection that has various symptoms such as fever and tingling and are followed by some other symptoms such as violent movements, uncontrolled excitement, fear of water etc. Fluorescent antibody test helps to detect rabies in animals and also helps to detect the presence of rabies virus antigens in brain tissue. Immunohistochemistry test are developed in order to enhance the accuracy of rabies diagnosis. Various other test such as polymerase chain reaction helps to confirm dFA results and also detect rabies virus in saliva and skin biopsy samples. Increasing prevalence of rabies and growing technological advancement is the major factor driving the growth of this market. Furthermore, increasing research and development activities in medical industry and increasing Neglected Tropical Diseases (NTDs) is set to further enhance the overall market demand for Rabies Diagnostics Market for the period 2021-2026. 

Report Coverage

The report: “Rabies Diagnostics Market Forecast (2021-2026)”, by IndustryARC, covers an in-depth analysis of the following segments of the Rabies Diagnostics Market.
By Diagnostic Method: Fluorescent Antibody Test (FAT), Immunohistochemistry Test, Amplification Method, Histologic Examination, and Serology Test
By Technology: Chemotherapy Techniques, PCR, and Others
By End-Use Industry: Hospitals, Diagnostics Center, and Others
By Geography: North America (U.S., Canada, Mexico), Europe (U.K, Germany, Italy, France, Spain, Russia, Rest of Europe), Asia Pacific (China, Australia, Japan, South Korea, India, Rest of Asia Pacific), South America (Brazil, Argentina, Others) and Rest of the World (Middle East, Africa)

Key Takeaways

  • Geographically, in 2020, North America dominated the Rabies Diagnostics Market owing to increasing advanced technologies for the diagnostic test, increasing geriatric population, and favorable reimbursement scenario.
  • Increasing prevalence of rabies and growing technological advancement are likely to aid in the market growth of the Rabies Diagnostics.  
  • Detailed analysis of the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Rabies Diagnostics Market report.   
  • High cost associated with diagnostics is set to create hurdles for the Rabies Diagnostics Market.   

Rabies Diagnostics Market Size, By End-Use Industry 2020-2026 (USD Million)

 Rabies Diagnostics Market
For More Details on This Report - Request for Sample

Rabies Diagnostics Segment Analysis – By Product

The global Rabies Diagnostics Market based on Product can be further segmented into Fluorescent Antibody Test (FAT), Immunohistochemistry Test, Amplification Method, Histologic Examination, and Serology Test. The Fluorescent Antibody Test (FAT) segment is the major segment generating revenue in 2020. This is mainly owing to increasing technological advancement and rising recommendation of FAT test by World Health Organization. Furthermore, FAT tests allow for simple and quick testing of samples and have been recorded to provide higher sensitivity, which boosts the market's growth. The Immunohistochemistry Test segment is estimated to register the fastest CAGR of 0.55% for the period 2021-2026. The cost-effectiveness, relative ease of interpretation using a standard light microscope, and reduced time consumption of immunohistochemistry-based methods are all factors driving this segment's development.

Rabies Diagnostics Segment Analysis – By End-Use Industry

The global Rabies Diagnostics Market based on End-Use Industry can be further segmented into Hospitals, Diagnostics Center, and Others. The Hospital segment registered for the highest Rabies Diagnostics market share in 2020. This is owing to hospitals offering various diagnostic test for rabies infection and increasing skilled professional in hospital. Moreover, increasing number of hospitals performing fluorescent antibody test with essential safety standards increases the growth of this market. The Diagnostics Center segment is estimated to register the fastest CAGR of 1.5% over 2021-2026. This is mainly owing to rising research and development and increasing number of diagnostic centers having immunohistochemistry diagnostics, increasing automation of diagnostic instruments and availability of advanced instruments and are increasing the growth of this market.

Rabies Diagnostics Segment Analysis – By Geography

North America dominated the Rabies Diagnostics Market with major share of 40% in 2020. This is owing to increasing advanced technologies for the diagnostic test, increasing geriatric population, and favorable reimbursement scenario. According to Center for Disease Control and Prevention (CDC), more than 120,000 animals are tested for rabies in U.S. in 2018 that increases the demand of rabies diagnostic test and are driving the growth of this market. However, Asia Pacific is estimated to be the fastest growing with a CAGR of 2.05% during the forecast period 2021-2026 owing to rising population and increasing development in healthcare. 

Rabies Diagnostics Market Drivers

Increasing Prevalence of Rabies 

Increasing prevalence of rabies owing to increasing cases are increasing the growth of the Rabies Diagnostics Market. According to World Health Organization (WHO), in 2018 rabies kills nearly 59,000 people that increases the need of polymerase chain reaction test that are increasing the growth of the Rabies Diagnostics Market over 2021-2026.   

Growing Technological Advancement

Technological advancements in the field of diagnostics, improvement in the research increases the growth of this Market. Various development such as Immunoperoxidase Antigen Detection (RIAD) helps to detect rabies that increases the rabies diagnostics test and are increasing the growth of Rabies Diagnostics Market over 2021-2026.  

Covid-19 Impact: 

COVID-19 pandemic had greatly affected the Rabies Diagnostics Market. During pandemic, healthcare sector are involved in recovering coronavirus cases. In hospitals, doctors are busy in coronavirus ward that decreases the use of diagnostics and are negatively impacted the growth of this market. 

Rabies Diagnostics Market Challenges

High Cost Associated with Diagnostics

The factors that is set to impede the growth of the Rabies Diagnostics Market are the high cost of technologies used for diagnosis. Moreover, lack of skilled professional in various healthcare sector is set to create hurdles for the Rabies Diagnostics Market.  

Rabies Diagnostics Landscape

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Rabies Diagnostics Market. Rabies Diagnostics top 10 companies include, Bio-Rad Laboratories, Inc., Merck KGaA, Aviva Systems Biology Corporation, Creative Diagnostics., Demeditec Diagnostics GmbH, Abbexa Ltd, Norgen Biotek Corp., BIONOTE Co., LTD, and Express Biotech International.

Development

  • In April 2019, Bio-Rad Laboratories are working to increase the development in healthcare sector that increases the growth of this market.

Relevant Reports:

Report Code: HCR 0021
Report Code: HCR 0176

For more Lifesciences and Healthcare Market reports, please click here
1. Rabies Diagnostics Market Overview
    1.1 Definitions and Scope
2. Rabies Diagnostics Market Executive Summary
    2.1 Market Size and Key Trends
    2.2 Key trends by Diagnostic Method
    2.3 Key trends by Technology
    2.4 Key trends by End-Use Industry
    2.5 Key trends by Geography
3. Rabies Diagnostics Market Landscape
    3.1 Market Share Analysis- Key Companies
    3.2 Product Benchmarking- Key Companies
    3.3 Financial Analysis - Key Companies
    3.4 Patent Analysis
    3.5 Pricing Analysis
4. Rabies Diagnostics Market- Startup companies Scenario Premium Premium
    4.1 Key startup company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Application Analysis
        4.1.4 Venture Capital and Funding Scenario
5. Rabies Diagnostics Market- Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of successful ventures
6. Rabies Diagnostics Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters Five Force Model
        6.3.1 Bargaining Power of Suppliers
        6.3.2 Bargaining Powers of Customers
        6.3.3 Threat of New Entrants
        6.3.4 Rivalry Among Existing Players
        6.3.5 Threat of Substitutes
7. Rabies Diagnostics Market Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Rabies Diagnostics Market– By Diagnostic Method (Market Size -$Million/$Billion)
    8.1 Fluorescent Antibody Test (FAT)
    8.2 Immunohistochemistry Test
    8.3 Amplification Method
    8.4 Histologic Examination
    8.5 Serology Test
9. Rabies Diagnostics Market– By Technology (Market Size -$Million/$Billion)
    9.1 Chemotherapy Techniques
    9.2 PCR
    9.3 Others
10. Rabies Diagnostics Market– By End-Use Industry (Market Size -$Million/$Billion)
    10.1 Hospitals
    10.2 Diagnostics Center
    10.3 Others
11. Rabies Diagnostics Market- By Geography (Market Size -$Million/$Billion)
    11.1 North America
        11.1.1 U.S.
        11.1.2 Canada
        11.1.3 Mexico
    11.2 Europe
        11.2.1 U.K.
        11.2.2 Germany
        11.2.3 Italy
        11.2.4 France
        11.2.5 Spain
        11.2.6 Russia
        11.2.7 Rest of Europe
    11.3 Asia-Pacific
        11.3.1 China
        11.3.2 Australia
        11.3.3 Japan
        11.3.4 South Korea
        11.3.5 India
        11.3.6 Rest of Asia-Pacific
    11.4 South America
        11.4.1 Brazil
        11.4.2 Argentina
        11.4.3 Others
    11.5 Rest of the World
        11.5.1 Middle East
        11.5.2 Africa
12. Rabies Diagnostics Market Entropy
13. Rabies Diagnostics Market- Industry / Segment Competition landscape Premium Premium
    13.1 Market Share Analysis
        13.1.1 Market Share by Country- Key companies
        13.1.2 Market Share by Region- Key companies
        13.1.3 Market Share at Global Level- Key companies
        13.1.4 Best Practices for Companies
14. Rabies Diagnostics Market- Key Company List by Country Premium Premium
15. Rabies Diagnostics Market Company Analysis
    15.1 Company Revenue, Products, M&A, Developments
    15.2 Company 1
    15.3 Company 2
    15.4 Company 3
    15.5 Company 4
    15.6 Company 5
    15.7 Company 6
    15.8 Company 7
    15.9 Company 8
    15.10 Company 9
    15.11 Company 10

LIST OF TABLES

1.Global Rabies Diagnostics Market:Competitive Landscape Market 2023-2030 ($M)
2.Global Rabies Diagnostics Market:Competitive Landscape Market 2023-2030 (Volume/Units)
3.North America Rabies Diagnostics Market:Competitive Landscape Market 2023-2030 ($M)
4.South America Rabies Diagnostics Market:Competitive Landscape Market 2023-2030 ($M)
5.Europe Rabies Diagnostics Market:Competitive Landscape Market 2023-2030 ($M)
6.APAC Rabies Diagnostics Market:Competitive Landscape Market 2023-2030 ($M)
7.MENA Rabies Diagnostics Market:Competitive Landscape Market 2023-2030 ($M)

LIST OF FIGURES

1.US Rabies Diagnostics Market Revenue, 2023-2030 ($M)
2.Canada Rabies Diagnostics Market Revenue, 2023-2030 ($M)
3.Mexico Rabies Diagnostics Market Revenue, 2023-2030 ($M)
4.Brazil Rabies Diagnostics Market Revenue, 2023-2030 ($M)
5.Argentina Rabies Diagnostics Market Revenue, 2023-2030 ($M)
6.Peru Rabies Diagnostics Market Revenue, 2023-2030 ($M)
7.Colombia Rabies Diagnostics Market Revenue, 2023-2030 ($M)
8.Chile Rabies Diagnostics Market Revenue, 2023-2030 ($M)
9.Rest of South America Rabies Diagnostics Market Revenue, 2023-2030 ($M)
10.UK Rabies Diagnostics Market Revenue, 2023-2030 ($M)
11.Germany Rabies Diagnostics Market Revenue, 2023-2030 ($M)
12.France Rabies Diagnostics Market Revenue, 2023-2030 ($M)
13.Italy Rabies Diagnostics Market Revenue, 2023-2030 ($M)
14.Spain Rabies Diagnostics Market Revenue, 2023-2030 ($M)
15.Rest of Europe Rabies Diagnostics Market Revenue, 2023-2030 ($M)
16.China Rabies Diagnostics Market Revenue, 2023-2030 ($M)
17.India Rabies Diagnostics Market Revenue, 2023-2030 ($M)
18.Japan Rabies Diagnostics Market Revenue, 2023-2030 ($M)
19.South Korea Rabies Diagnostics Market Revenue, 2023-2030 ($M)
20.South Africa Rabies Diagnostics Market Revenue, 2023-2030 ($M)
21.North America Rabies Diagnostics By Application
22.South America Rabies Diagnostics By Application
23.Europe Rabies Diagnostics By Application
24.APAC Rabies Diagnostics By Application
25.MENA Rabies Diagnostics By Application